| Trial ID: | L3543 |
| Source ID: | NCT03498001
|
| Associated Drug: |
Glp-1 Agonists
|
| Title: |
Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
|
| Acronym: |
LICAS-MR
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type II Diabetes
|
| Interventions: |
DRUG: GLP-1 agonists|PROCEDURE: Cardiac MRI|OTHER: Follow up by phone
|
| Outcome Measures: |
Primary: Change from Baseline Concentration of intramyocardial triglycerides at 6 months, Intramyocardial triglyceride concentration, expressed in %, evaluated by NMR spectroscopy, Month 6 |
|
| Sponsor/Collaborators: |
Sponsor: Centre Hospitalier Universitaire Dijon
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
42
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2018-04-16
|
| Completion Date: |
2023-12-20
|
| Results First Posted: |
|
| Last Update Posted: |
2024-02-20
|
| Locations: |
Chu Dijon Bourgogne, Dijon, 21000, France
|
| URL: |
https://clinicaltrials.gov/show/NCT03498001
|
